MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Botulinum toxin: Clinical applications: dystonia"

  • 2025 International Congress

    Precision Management of Oromandibular Dystonia (OMD): The Role of Neurological examination, Electromyographic (EMG) Guidance, and Odontological evaluation (OE) – A descriptive study with a Multidisciplinary Approach for Botulinum Toxin A (BoNT/A) Treatment

    A. Stark, H. Biernat, K. Benedek, P. Mcgettigan, M. Bakke, A. Lokkegaard (Rsokilde, Denmark)

    Objective: To demonstrate the advantages of OE, when facing challenges with identifying patterns of OMD for employment of EMG for guided BoNT/A precision management. Background:…
  • 2025 International Congress

    Use of Botulinum Toxin Application in the Inferior Oblique Capitis Muscle Under Tomographic Guidance in Cervical Dystonia Report of Two Cases

    I. Amorín, A. Rodriguez, N. Sorondo, B. Cardozo (Montevideo, Uruguay)

    Objective: To communicate the advantages of botulinum toxin application for dystonia under tomographic guidance in cervical muscles applying the Col/Cap concept. Background: The first case…
  • 2025 International Congress

    Long-Term Therapeutic Effect of Botulinum Neurotoxin Type A (BoNT-A) in Cervical Dystonia: A Case Series.

    R. Lopez-Castellanos, R. Lopez-Contreras (Boston, USA)

    Objective: To evaluate the long-term therapeutic effect of Botulinum neurotoxin type A (BoNT-A) in cervical dystonia. Background: Cervical dystonia is the most common adult-onset focal…
  • 2025 International Congress

    Development and Testing of a Smartphone Application to Capture Patient-Centered Outcome (PCO) Measures for Dystonia

    P. Reyes, A. Tingin, B. Berman, S. Schneider, J. Hieshetter, K. Kuman, G. Kilic-Berkmen, L. Wright, F. Qeadan, J. Perlmutter, H. Jinnah, S. Pirio-Richardson (Richmond, USA)

    Objective: Develop a smartphone application to collect patient-centered outcome (PCO) measures for dystonia. Background: PCO measures tailored for each major adult-onset focal dystonia subtype (Cervical…
  • 2024 International Congress

    Comparison in Therapeutic Outcome of Ultrasound-Guided Botulinum Injections for Limb Spasticity Versus Dystonia

    G. Yahalom, M. Cohen, I. Israel, R. Eichel, Y. Schechter (Jerusalem, Israel)

    Objective: To compare the therapeutic efficacy of BT injections for spasticity and dystonia in the limbs. Background: Botulinum toxin (BT) shows promise in alleviating limb…
  • 2024 International Congress

    Real-World Retrospective Safety Analysis in Patients Treated With OnabotulinumtoxinA for Multiple Therapeutic Indications Over Repeat Treatment Periods

    G. Forde, A. Patel, K. Martinez, A. Mayadev, B. Brucker, T. Brown, Z. Ayyoub, R. Singh, M. Nelson, A. Ukah, I. Yushmanova, S. Battucci, K. Becker Ifantides, C. Rhyne (New Hyde Park, USA)

    Objective: To evaluate the real-world safety of onabotulinumtoxinA (onabotA) use over repeat treatment periods (TPs) in patients (pts) with concomitant multiple therapeutic indications. Background: In…
  • 2024 International Congress

    Demographics of Botulinum toxin therapy population representative to demographics in Essex County, USA

    B. Puccio, Y. Xu, J. Acquaviva, E. Feinstein (Newark, USA)

    Objective: To describe and compare the demographics of patients receiving botulinum toxin therapy in a single movement disorder clinic to the broader surrounding community. Background:…
  • 2024 International Congress

    Tardive Dystonia Following Risperidone Treatment : A Case Report and Therapeutic Approach

    M. Hildaria, D. Tunjungsari, A. Tiksnadi (Central Jakarta, Indonesia)

    Objective: To report a case of tardive dystonia induced by risperidone and discuss the therapeutic approach, including the use of botulinum toxin. Background: Risperidone, a…
  • 2024 International Congress

    Disparities in Botulinum Toxin Utilization for Cervical Dystonia in a United States Medicare Population

    M. Verduzco-Gutierrez, A. Keener, I. Howard, D. Torres-Russotto, J. Sparrow, R. Kazerooni (San Antonio, USA)

    Objective: To examine the disparities in utilization of botulinum toxin (BoNT) injections for patients with cervical dystonia (CD) within the United States Medicare population. Background:…
  • 2024 International Congress

    Perceptions of Diseases in Patients with Cervical Dystonia

    D. Talkington, D. Sblendorio, K. Pyle, M. Coleman, M. Patel, M. Moreno-Escobar, A. Murray, A. Memon, J. Frey (Morgantown, USA)

    Objective: To explore how perception of disease can impact stigma, mood, quality of life, and severity of symptoms in patients with cervical dystonia (CD). Background:…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 21
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley